| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8222639 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 6 Pages |
Abstract
In patients with unresectable LAPC undergoing definitive chemoradiation therapy, baseline CA19-9 was independently prognostic even after established prognostic factors were controlled for, whereas CA19-9 progression strongly predicted disease progression and death. Future trials should stratify by baseline CA19-9 and incorporate CA19-9 progression as a criterion for progressive disease.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jeffrey M. MD, Matthew PhD, Mark M. MD, Theodore S. MD, PhD, Ross MD, Isaac R. MD, Gazala MD, William MD, Edgar MD,